Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bristol-Myers Squibb Co (BMY) vs Jabil Inc (JBL) Price & Performance

Bristol-Myers Squibb CoTrade

Price performance (Past 24H)

Key statistics

Bristol-Myers Squibb Co vs Jabil Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while Jabil Inc trades at $362.37 (market cap $37.37B). The key difference: Bristol-Myers Squibb Co is far larger — about 3.5× Jabil Inc's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.

BMYJBL
Market Cap
$129.94B$37.37B
Sector
HealthTechnology
52-Week High
$65.89$385.50
52-Week Low
$42.60$192.49
Enterprise Value
$163.92B$39.90B
Dividend Yield
3.96%0.09%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bristol-Myers Squibb Co

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Read more on BMY

About Jabil Inc

Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.

Read more on JBL